Valuation: Kenvue Inc.

Market Cap 37.11B 33.13B 30.4B 27.66B 51.85B 3,513B 52.88B 363B 146B 1,854B 139B 136B 5,857B P/E 2026 *
20.6x
P/E 2027 * 17.8x
Enterprise Value 44.26B 39.51B 36.26B 32.98B 61.84B 4,190B 63.07B 433B 175B 2,211B 166B 163B 6,985B EV / Sales 2026 *
2.84x
EV / Sales 2027 * 2.73x
Free-Float
98.87%
Yield 2026 *
4.39%
Yield 2027 * 4.45%
1 day-1.28%
1 week-1.33%
1 month+12.14%
3 months+0.36%
6 months+10.79%
Current year+11.94%
1 week 19.2
Extreme 19.2
20
1 month 17.16
Extreme 17.165
20
Current year 16.56
Extreme 16.555
20.13
1 year 15.88
Extreme 15.88
20.13
3 years 14.02
Extreme 14.02
25.17
5 years 14.02
Extreme 14.02
27.8
10 years 14.02
Extreme 14.02
27.8
Manager TitleAgeSince
Chief Executive Officer 56 14/07/2025
Director of Finance/CFO 48 12/05/2026
Chief Tech/Sci/R&D Officer 54 01/05/2023
Director TitleAgeSince
Chairman 70 01/05/2023
Director/Board Member 66 04/05/2023
Director/Board Member 59 08/05/2023
Date Insider Type Main position Quantity % Market Cap. Importance
02/10/26 Free

General Counsel

50,503 0.0026%
02/10/26 Free

Chief Operating Officer

50,946 0.0027%
02/10/26 Free

Chief Technology Officer

33,203 0.0017%
Change 5-day change 1-year change 3-year change Capi.($)
-1.28%-1.33%+34.38%+2.28% 37.11B
+1.55%+2.56%+10.81%+8.31% 374B
-0.10%+0.07%+20.63%+8.25% 260B
+0.63%-0.45%-5.23%+11.66% 140B
+2.11%+4.37%+29.59%+29.91% 75.75B
-0.70%+0.31%+26.40% - 54.59B
+1.81%+4.61%-23.01%-23.22% 46.14B
-2.16%-1.16%+15.35%-5.96% 39.52B
+0.99%-0.47%+6.69%-9.86% 35.9B
+0.51%-0.32%+15.52%+34.52% 21.52B
Average +0.35%+0.05%+13.11%+6.21% 108.52B
Weighted average by Cap. +0.71%+0.12%+12.67%+8.08%

Financials

2026 *2027 *
Net sales 15.61B 13.93B 12.79B 11.63B 21.81B 1,478B 22.24B 153B 61.56B 780B 58.58B 57.33B 2,463B 15.98B 14.27B 13.09B 11.91B 22.33B 1,513B 22.77B 156B 63.03B 798B 59.97B 58.69B 2,522B
Net income 1.84B 1.65B 1.51B 1.37B 2.58B 175B 2.63B 18.05B 7.28B 92.19B 6.92B 6.78B 291B 2.1B 1.87B 1.72B 1.56B 2.93B 199B 2.99B 20.53B 8.28B 105B 7.88B 7.71B 331B
Net Debt 7.15B 6.38B 5.86B 5.33B 9.99B 677B 10.19B 69.95B 28.2B 357B 26.83B 26.26B 1,128B 6.57B 5.87B 5.39B 4.9B 9.19B 622B 9.37B 64.33B 25.93B 328B 24.67B 24.15B 1,038B
Projected Income Statement - Annual - Kenvue Inc.
Logo Kenvue Inc.
Kenvue Inc. is one of the world leaders in the design, manufacture and marketing of consumer healthcare products. The group offers products for health, beauty, baby care, oral care, skin care and more. Net sales break down by family of products as follows: - self care products (42,3%): for the treatment of coughs, colds, allergies, pain, indigestion, constipation, etc. (brands Zyrtec, Benadryl, Zarbee's, Frenadol, Codral, Reactine, Tylenol, Motrin, Calpol, Nicorette, Imodium, Pepcid, Microlax, Daktarin, etc.); - personal care products (30.3%): primarily oral care, baby care, women's health and wound care products (Listerine, Desitin, Carefree, Stayfree, Band-Aid, Neosporin brands, etc.); - beauty and skin care products (27.4%): hair care products, sun protection products, face and body care products, etc. (Neutrogena, Aveeno, Clean&Clear, Lubriderm, Johnsons, Neostrata, OGX, Rogaine brands, etc.). Product marketing is assured through direct sales, distributors and the Internet. Net sales are distributed geographically as follows: North America (49%), Europe-Middle East-Africa (23%), Asia-Pacific (19.3%) and Latin America (8.7%).
Employees
21,890
Date Price Change Volume
30/10/26 $19.31 -1.28% 66,596,317
29/10/26 $19.56 +1.19% 12,324,528
28/10/26 $19.33 -0.51% 10,645,933
27/10/26 $19.43 -0.36% 15,866,807
26/10/26 $19.50 -0.36% 9,541,801
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Kenvue Inc.
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
19.31USD
Average target price
19.50USD
Spread / Average Target
+0.98%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Kenvue Inc.
  1. Stock Market
  2. Stocks
  3. KVUE Stock